Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
The author believes the AMA's Council on Ethical and Judicial Affairs should collaborate with academic physicians to create clear professional standards for the field of medicine.
The medical student believes that the art of doctoring is learned continuously over time and cannot be assessed in a proposed medical school examination.